Inventor · disambiguated record
Luc Buee
Also filed as: BUEE LUC
8 granted patents·5 pending applications·8 citations·filing 2005–2022
78Inventor score
Files withINST NAT SANTE RECH MED6ALZPROTECT3INNOGENETICS NV1INSERM INSTITUT NATIONAL DE LA SANTE ET DE LA RES MEDICALE1INSERM INSTITUTE NATIONAL DE LA SANTE ET DE LA RECH MEDICALE1
Top patents by PatentIndex Score
13 records- 0181US9562018B2Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the sameALZPROTECT·Filed 2013·Granted Feb 7, 2017·3 cites·7 claims
- 0275US8343493B2Antibodies specific of the β-amyloid peptides and their uses as diagnostic agents or drugsINNOGENETICS NV·Filed 2008·Granted Jan 1, 2013·4 cites·17 claims
- 0369US10772884B2Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the sameALZPROTECT·Filed 2019·Granted Sep 15, 2020·0 cites·8 claims
- 0464US2023032690A1New tau speciesINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 0561US10807958B21,4-bis(3-aminopropyl)piperazine derivative and its useINST NAT SANTE RECH MED·Filed 2018·Granted Oct 20, 2020·0 cites·6 claims
- 0660US9044478B2Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseasesSERGEANT NICOLAS·Filed 2005·Granted Jun 2, 2015·1 cites·12 claims
- 0758US2025134952A1Methods for improving the efficacy of hdac inhibitor therapy and predicting the response to treatment with hdac inhibitorINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 0857US2020407325A1Novel 1,4-bis(3-aminopropyl)piperazine derivative and its useINSERM INSTITUTE NATIONAL DE LA SANTE ET DE LA RECH MEDICALE·Filed 2020·Application pending·0 cites
- 0953US10537569B2Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the sameALZPROTECT·Filed 2016·Granted Jan 21, 2020·0 cites·10 claims
- 1049US12509505B2Anti Tau SVQIVYKPV epitope single domain antibodyINST NAT SANTE RECH MED·Filed 2019·Granted Dec 30, 2025·0 cites·7 claims
- 1147US2022177558A1Treatment of taupathy disorders by targeting new tau speciesINST NAT SANTE RECH MED·Filed 2020·Application pending·0 cites
- 1245US10017476B21,4-bis(3-aminopropyl)piperazine derivative and its useINSERM INSTITUT NATIONAL DE LA SANTE ET DE LA RES MEDICALE·Filed 2016·Granted Jul 10, 2018·0 cites·2 claims
- 1344US2020031891A1New tau speciesINST NAT SANTE RECH MED·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Luc Buee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →